Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C

Combination treatment of ledipasvir and sofosbuvir (LDV/SOF) is first‐line treatment for patients with chronic hepatitis C genotype 1 in the United States, Europe, and Japan. However, the influence of LDV/SOF on the cardiovascular system is poorly characterized. A total of 470 chronic hepatitis C pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahata, Yuki, Sakamori, Ryotaro, Urabe, Ayako, Morishita, Naoki, Yamada, Ryoko, Yakushijin, Takayuki, Hiramatsu, Naoki, Doi, Yoshinori, Kaneko, Akira, Hagiwara, Hideki, Yamada, Yukinori, Hijioka, Taizo, Inada, Masami, Tamura, Shinji, Imai, Yasuharu, Furuta, Kunimaro, Kodama, Takahiro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078212/
https://www.ncbi.nlm.nih.gov/pubmed/30094400
http://dx.doi.org/10.1002/hep4.1206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078212/
https://www.ncbi.nlm.nih.gov/pubmed/30094400
http://dx.doi.org/10.1002/hep4.1206

Ejemplares similares